Combined analysis of CCDC181, GCM2 and ITPRIPL1 was performed by Recursive Partitioning and Regression Trees (RPART) using 57 breast cancer and 134 health plasma samples from the subjects. This evidence concerns the gene GCM2 and breast cancer.